217 related articles for article (PubMed ID: 34135023)
1. Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation.
Abramson MH; Gutgarts V; Zheng J; Maloy MA; Ruiz JD; Scordo M; Jaimes EA; Sathick IJ
Clin J Am Soc Nephrol; 2021 Sep; 16(9):1318-1327. PubMed ID: 34135023
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Vergara-Cadavid J; Johnson PC; Kim HT; Yi A; Sise ME; Leaf DE; Hanna PE; Ho VT; Cutler CS; Antin JH; Gooptu M; Kelkar AH; Wells SL; Nikiforow S; Koreth J; Romee R; Soiffer RJ; Shapiro RM; Gupta S
Transplant Cell Ther; 2023 Jul; 29(7):455.e1-455.e9. PubMed ID: 37015320
[TBL] [Abstract][Full Text] [Related]
3. Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation.
Renaghan AD; Jaimes EA; Malyszko J; Perazella MA; Sprangers B; Rosner MH
Clin J Am Soc Nephrol; 2020 Feb; 15(2):289-297. PubMed ID: 31836598
[TBL] [Abstract][Full Text] [Related]
4. A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis.
Piñana JL; Perez-Pitarch A; Garcia-Cadenas I; Barba P; Hernandez-Boluda JC; Esquirol A; Fox ML; Terol MJ; Queraltó JM; Vima J; Valcarcel D; Ferriols-Lisart R; Sierra J; Solano C; Martino R
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1177-1185. PubMed ID: 28396159
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Acute Kidney Injury and Chronic Kidney Disease following Allogeneic Hematopoietic Stem Cell Transplantation for Hematopoietic Malignancies.
Sakaguchi M; Nakayama K; Yamaguchi H; Mii A; Shimizu A; Inai K; Onai D; Marumo A; Omori I; Yamanaka S; Fujiwara Y; Fukunaga K; Ryotokuji T; Hirakawa T; Okabe M; Tamai H; Okamoto M; Wakita S; Yui S; Tsuruoka S; Inokuchi K
Acta Haematol; 2020; 143(5):452-464. PubMed ID: 31822013
[TBL] [Abstract][Full Text] [Related]
6. Urinary elafin and kidney injury in hematopoietic cell transplant recipients.
Hingorani S; Finn LS; Pao E; Lawler R; Schoch G; McDonald GB; Najafian B; Sandmaier B; Gooley T
Clin J Am Soc Nephrol; 2015 Jan; 10(1):12-20. PubMed ID: 25388519
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for acute kidney injury in pediatric patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Huang B; Shan J; Yi L; Xin Y; Zhong Z; Xu H
Pediatr Nephrol; 2024 Feb; 39(2):397-408. PubMed ID: 37079103
[TBL] [Abstract][Full Text] [Related]
8. Hyperferritinemia and acute kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation.
Kurokawa M; Nishiyama K; Koga Y; Eguchi K; Imai T; Oba U; Shiraishi A; Nagata H; Kaku N; Ishimura M; Honjo S; Ohga S
Pediatr Nephrol; 2020 Oct; 35(10):1977-1984. PubMed ID: 32488669
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Yu ZP; Ding JH; Chen BA; Liu BC; Liu H; Li YF; Ding BH; Qian J
Chin J Cancer; 2010 Nov; 29(11):946-51. PubMed ID: 20979694
[TBL] [Abstract][Full Text] [Related]
10. Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study.
Rodrigues N; Costa C; Branco C; Martins C; Lopes JA
J Nephrol; 2024 Mar; 37(2):419-428. PubMed ID: 38019417
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Ataei S; Hadjibabaie M; Moslehi A; Taghizadeh-Ghehi M; Ashouri A; Amini E; Gholami K; Hayatshahi A; Vaezi M; Ghavamzadeh A
Hematol Oncol; 2015 Jun; 33(2):67-74. PubMed ID: 24711000
[TBL] [Abstract][Full Text] [Related]
12. Deceased-Donor Acute Kidney Injury and BK Polyomavirus in Kidney Transplant Recipients.
Hall IE; Reese PP; Mansour SG; Mohan S; Jia Y; Thiessen-Philbrook HR; Brennan DC; Doshi MD; Muthukumar T; Akalin E; Harhay MN; Schröppel B; Singh P; Weng FL; Bromberg JS; Parikh CR
Clin J Am Soc Nephrol; 2021 May; 16(5):765-775. PubMed ID: 33692117
[TBL] [Abstract][Full Text] [Related]
13. Acute Kidney Injury in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation: Incidence, Risk Factors, and Outcomes.
Koh KN; Sunkara A; Kang G; Sooter A; Mulrooney DA; Triplett B; Onder AM; Bissler J; Cunningham LC
Biol Blood Marrow Transplant; 2018 Apr; 24(4):758-764. PubMed ID: 29196074
[TBL] [Abstract][Full Text] [Related]
14. AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients.
Kim H; Ali R; Short S; Kaunfer S; Krishnamurthy S; Durai L; Yilmam O; Shenoy T; Monson AE; Thomas C; Park I; Martini D; Newcomb R; Shapiro RM; Soiffer RJ; DeFilipp Z; Baron RM; Gupta S; Sise ME; Leaf DE
Bone Marrow Transplant; 2024 Feb; 59(2):178-188. PubMed ID: 37935783
[TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury after allogeneic hematopoietic stem cell transplantation - Predictors and survival impact: A single center retrospective study.
Menezes MDM; Marques AI; Chuva T; Pinho Vaz C; Ferreira H; Branca R; Paiva A; Campos A; Maximino Costa J
Nefrologia (Engl Ed); 2022; 42(6):656-663. PubMed ID: 36402680
[TBL] [Abstract][Full Text] [Related]
16. Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19.
Bowe B; Cai M; Xie Y; Gibson AK; Maddukuri G; Al-Aly Z
Clin J Am Soc Nephrol; 2020 Dec; 16(1):14-25. PubMed ID: 33199414
[TBL] [Abstract][Full Text] [Related]
17. Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis.
Gutiérrez-García G; Villarreal J; Garrote M; Rovira M; Blasco M; Suárez-Lledó M; Rodríguez-Lobato LG; Charry P; Rosiñol L; Marín P; Pedraza A; Solano MT; Ramos C; de Llobet N; Lozano M; Cid J; Martínez C; Poch E; Carreras E; Urbano-Ispizua Á; Fernández-Avilés F; Pereira A; Quintana LF
Bone Marrow Transplant; 2020 Jul; 55(7):1264-1271. PubMed ID: 32103146
[TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
19. Correlates and Outcomes of Early Acute Kidney Injury after Hematopoietic Cell Transplantation.
Bhasin B; Ber Ce P; Szabo A; Chhabra S; D'Souza A
Am J Med Sci; 2021 Jul; 362(1):72-77. PubMed ID: 33812909
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Kidney Injury and Associations with Critical Illness and Death in Patients with COVID-19.
Zheng X; Yang H; Li X; Li H; Xu L; Yu Q; Dong Y; Zhao Y; Wang J; Hou W; Zhang X; Li Y; Hu F; Gao H; Lv J; Yang L
Clin J Am Soc Nephrol; 2020 Nov; 15(11):1549-1556. PubMed ID: 32943396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
